Review
[Monoclonal antibodies in the treatment of malignant lymphoma]
[Article in
Chinese]
Affiliations
- PMID: 16900652
Item in Clipboard
Review
[Monoclonal antibodies in the treatment of malignant lymphoma]
[Article in
Chinese]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao.
2006 Jun.
Abstract
Monoclonal antibodies (MoAbs) have different mechanism and adverse effects compared with cytotoxic agents. The introduction of MoAbs has improved the treatment potency to malignant lymphoma without decreasing the quality of life. However, there are many questions to be answered: What is the profound mechanism of MoAbs? How about their long-term adverse effects? What is the best medication pattern in different disease types?
Similar articles
-
[Monoclonal antibody treatment of malignant lymphoma].Internist (Berl). 2004 Dec;45(12):1370-7. doi: 10.1007/s00108-004-1299-z. Internist (Berl). 2004. PMID: 15517123 Review. German.
-
[Advancement of biotherapy for malignant lymphoma].Ai Zheng. 2005 Aug;24(8):1027-32. Ai Zheng. 2005. PMID: 16086888 Review. Chinese.
-
[Innovative antibody-therapies for malignant lymphomas].Dtsch Med Wochenschr. 2005 Dec 2;130(48):2783-8. doi: 10.1055/s-2005-922073. Dtsch Med Wochenschr. 2005. PMID: 16307409 Review. German.
-
Role of antibody therapy in lymphoid malignancies.Br Med Bull. 2007;83:275-90. doi: 10.1093/bmb/ldm025. Br Med Bull. 2007. PMID: 17942451 Review.
-
Combination of chemotherapy and monoclonal antibodies for the treatment of lymphoma.Int J Hematol. 2002 Dec;76(5):394-400. doi: 10.1007/BF02982804. Int J Hematol. 2002. PMID: 12512833 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical